A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord-Reference-Cited by-同舟云学术

A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord

Published:2006-11-12 Issue:12 Volume:12 Page:1380-1389
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kaneko Shinjiro,Iwanami Akio,Nakamura Masaya,Kishino Akiyoshi,Kikuchi Kaoru,Shibata Shinsuke,Okano Hirotaka J,Ikegami Takeshi,Moriya Ayako,Konishi Osamu,Nakayama Chikao,Kumagai Kazuo,Kimura Toru,Sato Yasufumi,Goshima Yoshio,Taniguchi Masahiko,Ito Mamoru,He Zhigang,Toyama Yoshiaki,Okano Hideyuki

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1505.pdf

Reference50 articles.

1. Schwab, M.E., Kapfhammer, J.P. & Bandtlow, C.E. Inhibitors of neurite growth. Annu. Rev. Neurosci. 16, 565–595 (1993).

2. GrandPre, T., Nakamura, F., Vartanian, T. & Strittmatter, S.M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 403, 439–444 (2000).

3. Chen, M.S. et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434–439 (2000).

4. Domeniconi, M. et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35, 283–290 (2002).

5. Olson, L. Medicine: clearing a path for nerve growth. Nature 416, 589–590 (2002).

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The top 100 most cited articles on axon regeneration from 2003 to 2023: a bibliometric analysis;Frontiers in Neuroscience;2024-06-26

2. The role of semaphorin 3A on chondrogenic differentiation;In Vitro Cellular & Developmental Biology - Animal;2024-05-10

3. Semaphorin3C identified as mediator of neuroinflammation and microglia polarization after spinal cord injury;iScience;2024-05

4. Semaphorins in tumor microenvironment: Biological mechanisms and therapeutic progress;International Immunopharmacology;2024-05

5. Mertk Reduces Blood-Spinal Cord Barrier Permeability Through the Rhoa/Rock1/P-MLC Pathway After Spinal Cord Injury;Neuroscience Bulletin;2024-04-09